Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events
Status:
Terminated
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This study is being carried out to study the efficacy and safety of treatment with melagatran
injection followed by ximelagatran tablets in preventing blood clots, compared with
enoxaparin for a period of 5-6 weeks. A separate visit, independent from the study will be
done approximately 6 months after the surgery.